Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic to Market, Sell Nanogen s NanoChip Platform in Parts of Europe

NEW YORK, Jan. 15 (GenomeWeb News) - Transgenomic will market and sell Nanogen's NanoChip molecular biology workstation in selected Western European countries, the companies said today.

 

The reason, according to both companies, is that the NanoChip platform "complements" the ability of Transgenomic's WAVE system to scan for unknown gene mutations, and that Transgenomic "has a large, well-established European customer base."

 

"This agreement is part of a strategy of providing total complementary solutions for the genetic research and clinical laboratory markets in Europe," said Collin D'Silva, Transgenomic's CEO.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.